WORCESTER, Mass.--(BUSINESS WIRE)--Generex Biotechnology Corporation (NasdaqCM: GNBT, www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, is featured in an interview segment on FOXNews.com concerning Generex Oral-lyn™, the company’s flagship proprietary oral insulin spray product.
